Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026

Go back to Achieve Life Sciences to Present 52-Week Cytisinicline Efficacy Data for Smoking and E-Cigarette Cessation at CHEST 2026
(NASDAQ: ACHV) Delayed: 6.50 -0.01 (0.15%)
Previous Close $6.51    52 Week High $ 
Open $6.39    52 Week Low $ 
Day High $6.64    P/E N/A 
Day Low $6.33    EPS $ 
Volume 963,292